Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study

Association of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study

(2014) Gabriel Y. Lai et al.   CANCER CAUSES & CONTROL

Effect of metabolic syndrome and its components on prostate cancer risk: Meta-analysis

(2014) K. Esposito et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence

(2013) Yu-zhu Xiang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Minireview: The Molecular and Genomic Basis for Prostate Cancer Health Disparities

(2013) Isaac J. Powell et al.   MOLECULAR ENDOCRINOLOGY

Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study

(2013) S J Freedland et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Metabolic syndrome increases the risk of aggressive prostate cancer detection

(2012) Juan Morote et al.   BJU INTERNATIONAL

Prostate Cancer Risk in Men with Baseline History of Coronary Artery Disease: Results from the REDUCE Study

(2012) J.-A. Thomas et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Androgens, diabetes and prostate cancer

(2012) Mathis Grossmann et al.   ENDOCRINE-RELATED CANCER

International Variation in Prostate Cancer Incidence and Mortality Rates

(2012) Melissa M. Center et al.   EUROPEAN UROLOGY

The Metabolic Syndrome and Risk of Prostate Cancer in Italy

(2011) Claudio Pelucchi et al.   ANNALS OF EPIDEMIOLOGY

Metabolic syndrome: definitions and controversies

(2011) Eva Kassi et al.   BMC Medicine

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The Correlation Between Metabolic Syndrome and Prostatic Diseases

(2011) Cosimo De Nunzio et al.   EUROPEAN UROLOGY

Prostate cancer and inflammation: the evidence

(2011) Karen S Sfanos et al.   HISTOPATHOLOGY

The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: results from the Olmsted County Study

(2010) Lauren P. Wallner et al.   BJU INTERNATIONAL

Statin medication use and the risk of biochemical recurrence after radical prostatectomy

(2010) Robert J. Hamilton et al.   CANCER

The Metabolic Syndrome and the Risk of Prostate Cancer under Competing Risks of Death from Other Causes

(2010) B. Grundmark et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Effect of Dutasteride on the Risk of Prostate Cancer

(2010) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway

(2009) Richard M. Martin et al.   CANCER CAUSES & CONTROL

Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer

(2009) Konstantinos K. Tsilidis et al.   CANCER CAUSES & CONTROL

Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial

(2009) E. A. Platz et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

A 25-Year Prospective Study of Plasma Adiponectin and Leptin Concentrations and Prostate Cancer Risk and Survival

(2009) H. Li et al.   CLINICAL CHEMISTRY

Racial Differences in Risk of Prostate Cancer Associated With Metabolic Syndrome

(2009) Jennifer L. Beebe-Dimmer et al.   UROLOGY

Serum Prostate-Specific Antigen Levels in Men With Type 2 Diabetes

(2008) M. Fukui et al.   DIABETES CARE

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

(2008) Jing Ma et al.   LANCET ONCOLOGY